Cerebrospinal fluid changes after iopamidol and metrizamide myelography in clinically normal dogs.

Am J Vet Res

Department of Veterinary Clinical Sciences, School of Veterinary Medicine, Purdue University, West Lafayette, IN 47907.

Published: March 1992

Cerebrospinal fluid samples from 2 groups of clinically normal dogs were compared after iopamidol (n = 9) and metrizamide (n = 8) myelography. Iopamidol (200 mg of I/ml) and metrizamide (170 mg of I/ml) were administered by cerebellomedullary injection at dosage of 0.45 ml/kg of body weight. In dogs of both groups, postmyelographic CSF changes included high specific gravity, Pandy score, protein concentration, and WBC count. The high specific gravity and Pandy score were false-positive effects attributed to nonionic contrast media. Although postmyelographic protein concentration and total WBC count were greater in CSF samples from dogs given metrizamide than in those given iopamidol, differences were not statistically significant. The differential WBC counts were consistent with mild, acute leptomeningitis; these findings were supported by results of histologic examination. Iopamidol and metrizamide should be considered low-grade leptomeningeal irritants in dogs.

Download full-text PDF

Source

Publication Analysis

Top Keywords

iopamidol metrizamide
12
cerebrospinal fluid
8
metrizamide myelography
8
clinically normal
8
normal dogs
8
high specific
8
specific gravity
8
gravity pandy
8
pandy score
8
protein concentration
8

Similar Publications

Photon interaction performance of various contrast agents: Theoretical and simulation results.

Appl Radiat Isot

November 2021

Afyonkarahisar Health Sciences University, Atatürk Vocational School of Health Service, Department of Medical Imaging Techniques, 03200, Afyonkarahisar, Turkey. Electronic address:

In this study, total mass attenuation coefficient (μ/ρ) values in the energy range from 60 keV to 15 MeV for some contrast agents (Iopamidol, Metrizamide, Iohexol, Ioxaglic acid, Iopromide, Ioversol and Iopentol) were determined with the WinXCOM computer program and GEANT4 computer simulation code. Linear attenuation coefficients (μ), half value layers (HVL), tenth value layers (TVL), mean free paths (mfp), effective atomic numbers (Z) and effective electron densities (N) in the aforementioned energy range were obtained with the help of the calculated total mass attenuation coefficients. Energy absorption build-up factors (EABF) and exposure build-up factors (EBF) for contrast agents were calculated using the five-parameter geometric progression (G-P) fitting method in the energy region of 0.

View Article and Find Full Text PDF

Sclerotherapy for venous malformations using a "negative subtraction" technique.

Neuroradiology

February 2006

Division of Neuroradiology, Department of Radiology, Hadassah Hebrew University Hospital, Jerusalem, Israel.

We describe a technique of injecting alcohol into venous malformations (VM) under slow digital subtraction angiography (DSA) which eliminates the need to pre-mix the alcohol with a contrast agent. The technique presented here is especially helpful when Metrizamide is not available or not permitted for use. It offers an elegant way to visualize, in real time, the alcohol injected into the VM, while preserving its high concentration and potency as a sclerosing agent.

View Article and Find Full Text PDF

An overview of the clinical pharmacokinetics of x-ray contrast media.

Clin Pharmacokinet

March 1997

Département de Pharmacologie Clinique et GIS Médicament, Faculté de Médecine, Nantes, France.

Pharmacokinetic studies of contrast media are usually performed as preclinical trials in anaesthetised animals; however, results in humans have also been reported for this type of compounds. This paper reviews the existing data about x-ray contrast media in humans. In some cases, animal data are used in areas where no human data are available.

View Article and Find Full Text PDF

Adverse reactions in myelography.

Acta Radiol Suppl

May 1996

Department of Diagnostic Radiology, Malmö University Hospital, Sweden.

An attempt was made to assess the usefulness of using animal models to predict the neural tolerability in man of iodinated contrast media (CM) in general, and of the new nonionic dimer iodixanol in particular. For this purpose, the results from 6 animal experiments evaluating excitative and depressive effects of subarachnoidally injected CM in nonanesthetized rabbits were compared with the results from 22 randomized double-blind clinical trials dealing with post-myelographic adverse reactions. Comparisons were made as regards the nonionic monomers metrizamide, iohexol, and iopamidol, and the dimer iotrolan.

View Article and Find Full Text PDF

Myelography and epidurography.

Vet Clin North Am Small Anim Pract

March 1993

Department of Anatomy and Radiology, University of Georgia College of Veterinary Medicine, Athens.

To summarize the points discussed in this article, Small animal myelography can be performed competently and safely without specialized equipment. The newer myelographic contrast media (iohexol, iopamidol) have less neurotoxic potential than those media previously used. Myelography is necessary for the diagnosis of many neurologic disorders in small animals.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!